Table of Contents

company-logo

Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule for treating epilepsies. It also develops OV882, a short hairpin RNA gene therapy for the treatment of angelman syndrome; and OV815 for the treatment of kinesin-family of proteins associated neurological disorder. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, and Northwestern University, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.

Ovid Therapeutics Dividend Announcement

• Ovid Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Ovid Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Ovid Therapeutics Dividend History

Ovid Therapeutics Dividend Yield

Ovid Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Ovid Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Ovid Therapeutics Financial Ratios

P/E ratio-2.56
PEG ratio0.02
P/B ratio1.09
ROE-39.24%
Payout ratio0.00%
Current ratio5.66
Quick ratio5.66
Cash Ratio1.29

Ovid Therapeutics Dividend FAQ

Does Ovid Therapeutics stock pay dividends?
Ovid Therapeutics does not currently pay dividends to its shareholders.
Has Ovid Therapeutics ever paid a dividend?
No, Ovid Therapeutics has no a history of paying dividends to its shareholders. Ovid Therapeutics is not known for its dividend payments.
Why doesn't Ovid Therapeutics pay dividends?
There are several potential reasons why Ovid Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Ovid Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Ovid Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Ovid Therapeutics a dividend aristocrat?
Ovid Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Ovid Therapeutics a dividend king?
Ovid Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Ovid Therapeutics a dividend stock?
No, Ovid Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Ovid Therapeutics stocks?
To buy Ovid Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Ovid Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.